Eclinical Insights Inc is categorized under Commercial Medical Research in Cambridge, MA and active since 1996.
Eclinical Insights Inc was established in 1996, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Margaret Regan at the company’s single location by writing to 10 Fawcett St # 3, Cambridge, Massachusetts MA 02138 or by phoning (617) 871-2500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eclinical Insights Inc |
| Contact Person: | Margaret Regan |
| Address: | 10 Fawcett St # 3, Cambridge, Massachusetts 02138 |
| Phone Number: | (617) 871-2500 |
| Website Address: | pharmapros.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Eclinical Insights Inc was started in 1996 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Margaret Regan for inquiries that concern Eclinical Insights Inc by calling the company number (617) 871-2500, as your correspondence is most welcome. Additionally, the physical location of the single location of Eclinical Insights Inc can be found at the coordinates 42.389284,-71.145818 as well as the street address 10 Fawcett St # 3 in Cambridge, Massachusetts 02138.
For its online presence, you may visit Eclinical Insights Inc’s website at pharmapros.com and engage with its social media outlets through on Twitter and on Facebook.